Alastair Lewis/LinkedIn
Nov 28, 2025, 16:20
Alastair Lewis: Powerful TIRS Outcomes in Venous Ulcer Prevention
Alastair Lewis, Vascular Surgeon at Fitzwilliam Health Clinic, posted on LinkedIn:
”Terminal Interruption of Reflux Source (TIRS) in pre-ulceration.
54-year-old male, 6-month history of progressive swelling, itch, and evolving skin change,s and 3-4 week active flare-up of LDS in the right pre-tibial area. History of EVLT and healed venous ulcer, left leg in 2022.
Duplex findings
- Great saphenous vein 8mm in thigh, 5mm in calf.
- 4-5mm varicosities arising from GSV tributaries.
- Extensive venous plexus underlying LDS
Treatment
- Single session of ultrasound-guided foam sclerotherapy performed in a peripheral-to-proximal manner.
- 8mls 0.2% Varixio STS foam to sub-LDS plexus
- 8mls 0.5% Varixio STS foam to the varicose veins and calf segment of GSV
- 4mls 3% STS foam, physician-compounded, thigh GSV
- Class 2 compression stockings for 2 weeks
Outcome
- Immediate relief of itch and swelling 24 hours following treatment.
- 8 week review – duplex confirms occlusion of GSV, varicose veins, and sub-LDS plexus
- Clinically – almost complete resolution of swelling, inactive skin changes remain
- This experience underscores the value of early intervention for venous disease complications and highlights the effectiveness of targeting peripheral venous plexuses in patients at risk of ulceration.”

Stay updated with Hemostasis Today.
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
-
Nov 29, 2025, 16:38PF4 Antibody Persistence and Long-term Pathogenicity in VITT
